Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine



Status:Completed
Conditions:Diabetes, Diabetes, Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - Any
Updated:2/20/2019
Start Date:August 2, 2017
End Date:January 12, 2019

Use our guide to learn which trials are right for you!

Six-month, Randomized, Open-label, Parallel-group Comparison of SAR341402 to NovoLog®/NovoRapid® in Adult Patients With Diabetes Also Using Insulin Glargine, With a 6-month Safety Extension Period

Primary Objective:

To demonstrate non-inferiority of SAR341402 versus NovoLog/NovoRapid in glycated hemoglobin
A1c (HbA1c) change from baseline to Week 26 in patients with type 1 or type 2 diabetes
mellitus (T1DM or T2DM) also using Lantus®.

Secondary Objectives:

- To assess the immunogenicity of SAR341402 and NovoLog/NovoRapid in terms of
positive/negative status and anti-insulin antibody (AIA) titers during the course of the
study.

- To assess the relationship of AIAs with efficacy and safety.

- To assess the efficacy of SAR341402 and NovoLog/NovoRapid in terms of proportion of
patients reaching HbA1c <7.0% and change in HbA1c, fasting plasma glucose (FPG), and
self-measured plasma glucose (SMPG) profiles from baseline to Week 26 and Week 52 (only
Week 52 for HbA1c).

- To assess safety of SAR341402 and NovoLog/NovoRapid.

The study will consist of a 2-week screening period, a 26-week treatment period, a 26-week
comparative safety extension period, and a 1-day follow-up period. The maximum study duration
will then be 54 weeks per patient and a 1 day safety follow-up.

Inclusion criteria :

- Patients with T1DM or T2DM (T2DM US only) diagnosed for at least 12 months, who have
been treated with a multiple daily injection regimen with

- NovoLog/NovoRapid OR insulin lispro (100 U/mL) in the last 6 months prior to screening
visit AND

- insulin glargine (100 U/mL) in the last 6 months prior to screening visit OR insulin
detemir (Levemir®) in the last 12 months prior to screening visit.

Exclusion criteria:

- At screening visit, age under legal age of adulthood.

- Glycated hemoglobin (HbA1c) <7.0% or >10% at screening.

- Less than 1 year on continuous insulin treatment.

- Use of insulin pump in the last 3 months before screening visit.

- Patients with incomplete baseline 7-point SMPG profile, defined as patients who do not
have 7-point profiles with at least 5 points on at least 2 days in the week before
randomization Visit 3.

- Patients with T1DM: Use of glucose lowering agents other than insulin including use of
non-insulin injectable peptides in the last 3 months prior to screening.

- Patients with T2DM:

- Use of glucagon-like peptide-1 (GLP-1) receptor agonists in the last 3 months
before screening visit.

- Use of oral antidiabetic drugs (OADs) not on stable dose in the last 3 months
before screening visit (sulfonylureas will be discontinued at baseline).

- At screening visit, body mass index (BMI) ≥35 kg/m2 in patients with T1DM and ≥40
kg/m2 in patients with T2DM.

- Use of insulin other than:

- insulin glargine 100 U/mL and NovoLog/NovoRapid or insulin lispro 100 U/mL as
part of a multiple injection regimen in the last 6 months before screening visit,
OR

- insulin detemir 100 U/mL in the 12 months before screening visit and
NovoLog/NovoRapid or insulin lispro 100 U/mL in the last 6 months before
screening visit as part of a multiple injection regimen.

- Status post pancreatectomy.

- Status post pancreas and/or islet cell transplantation.

- Hospitalization for recurrent diabetic ketoacidosis in the last 3 months before
screening visit.

- History of severe hypoglycemia requiring Emergency Room admission or hospitalization
in the last 3 months before screening visit.

- Unstable proliferative diabetic retinopathy or any other rapidly progressive diabetic
retinopathy or macular edema likely to require treatment (eg, laser, surgical
treatment or injectable drugs) during the study period.

- Pregnant or breastfeeding women.

- Women of childbearing potential not protected by highly effective method(s) of birth
control.

The above information is not intended to contain all considerations relevant to a patient's
potential participation in a clinical trial.
We found this trial at
39
sites
1121
mi
from
Rockville, MD
Click here to add this to my saved trials
Arlington Heights, Illinois 60004
601
mi
from
Arlington Heights, IL
Click here to add this to my saved trials
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
402
mi
from
Aurora, CO
Click here to add this to my saved trials
522
mi
from
Austin, TX
Click here to add this to my saved trials
1296
mi
from
Bend, OR
Click here to add this to my saved trials
Bridgeport, West Virginia 26330
954
mi
from
Bridgeport, WV
Click here to add this to my saved trials
719
mi
from
Chattanooga, TN
Click here to add this to my saved trials
811
mi
from
Columbus, GA
Click here to add this to my saved trials
154
mi
from
Concord, CA
Click here to add this to my saved trials
349
mi
from
Dallas, TX
Click here to add this to my saved trials
346
mi
from
Des Moines, IA
Click here to add this to my saved trials
408
mi
from
Englewood, CO
Click here to add this to my saved trials
1127
mi
from
Escondido, CA
Click here to add this to my saved trials
635
mi
from
Fargo, ND
Click here to add this to my saved trials
822
mi
from
Flint, MI
Click here to add this to my saved trials
1210
mi
from
Fresno, CA
Click here to add this to my saved trials
1343
mi
from
Greenbrae, CA
Click here to add this to my saved trials
954
mi
from
Henderson, NV
Click here to add this to my saved trials
569
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
Jyväskylä,
Click here to add this to my saved trials
1118
mi
from
La Jolla, CA
Click here to add this to my saved trials
372
mi
from
Little Rock, AR
Click here to add this to my saved trials
1168
mi
from
Los Angeles, CA
Click here to add this to my saved trials
350
mi
from
Mesquite, TX
Click here to add this to my saved trials
690
mi
from
Metairie, LA
Click here to add this to my saved trials
Morehead City, North Carolina 28557
1189
mi
from
Morehead City, NC
Click here to add this to my saved trials
1091
mi
from
New Port Richey, FL
Click here to add this to my saved trials
1290
mi
from
New York, NY
Click here to add this to my saved trials
1133
mi
from
Ocoee, FL
Click here to add this to my saved trials
262
mi
from
Omaha, NE
Click here to add this to my saved trials
1140
mi
from
Pomona, CA
Click here to add this to my saved trials
1382
mi
from
Renton, WA
Click here to add this to my saved trials
797
mi
from
Roswell, GA
Click here to add this to my saved trials
779
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Santa Barbara, California 93105
1242
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
1217
mi
from
Ventura, CA
Click here to add this to my saved trials
1435
mi
from
Waltham, MA
Click here to add this to my saved trials
Wilmington, North Carolina 28401
1135
mi
from
Wilmington, NC
Click here to add this to my saved trials